Document is current
Any future updates will be listed below
-
Authors
Frölke, Jan Paul
Aschoff, Horst
Van de Meent, Henk
Mittlmeier, Thomas
- License Information
-
More Information
Article History
Received: 15 April 2024
Revised: 13 October 2024
Accepted: 14 October 2024
First Online: 14 March 2025
Declarations
:
: H. Van de Meent is CEO for the company OTN Implants Germany GmbH. J.P. Frölke, H. Aschoff, and T. Mittlmeier declare that they have no competing interests.
: All procedures followed were in accordance with the ethical standards of the responsible institutional committees and with the Helsinki Declaration of 1975. Informed consent was obtained from all patients included in the study.
